BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9780154)

  • 1. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice.
    Gilkeson GS; Conover J; Halpern M; Pisetsky DS; Feagin A; Klinman DM
    J Immunol; 1998 Oct; 161(8):3890-5. PubMed ID: 9780154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
    Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
    Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased autoantibody production by NZB/NZW B cells in response to IL-5.
    Herron LR; Coffman RL; Bond MW; Kotzin BL
    J Immunol; 1988 Aug; 141(3):842-8. PubMed ID: 2969393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.
    Gilkeson GS; Pippen AM; Pisetsky DS
    J Clin Invest; 1995 Mar; 95(3):1398-402. PubMed ID: 7883986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the inhibitory effects of interferon-gamma on interleukin-4-induced stimulation of resting B cells from NZB/NZW F1 mice.
    Minoda M; Hamada K; Higashikawa M; Sugishima H; Funauchi M; Horiuchi A
    Clin Exp Immunol; 1989 Oct; 78(1):115-9. PubMed ID: 2509118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.
    Redford TW; Yi AK; Ward CT; Krieg AM
    J Immunol; 1998 Oct; 161(8):3930-5. PubMed ID: 9780160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma inhibition of interleukin 4-induced hyperproliferation of resting B cell from NZB/NZW F1 mice.
    Minoda M; Ohno M; Hamada K; Tomioka Y; Funauchi M; Horiuchi A
    J Clin Lab Immunol; 1991 Jun; 35(2):57-63. PubMed ID: 1668759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA.
    Wloch MK; Alexander AL; Pippen AM; Pisetsky DS; Gilkeson GS
    J Immunol; 1997 May; 158(9):4500-6. PubMed ID: 9127017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
    Gilkeson GS; Ruiz P; Pippen AM; Alexander AL; Lefkowith JB; Pisetsky DS
    J Exp Med; 1996 Apr; 183(4):1389-97. PubMed ID: 8666897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice.
    Yang BC; Liu CW; Chen YC; Yu CK
    Immunol Invest; 1998; 27(4-5):291-302. PubMed ID: 9730089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K
    Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
    Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
    Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.